Related Experiment Video
Updated: Apr 18, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory
Jing-Qing Zeng1, Chun-Di Xu1, Tong Zhou1
1Jing-Qing Zeng, Chun-Di Xu, Tong Zhou, Jing Wu, Kai Lin, Wei Liu, Xin-Qiong Wang, Department of Pediatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) expression increases in intestinal epithelial cells during inflammatory bowel disease (IBD), correlating with disease severity. Targeting DC-SIGN may offer a therapeutic strategy for IBD.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Inflammatory bowel disease (IBD) involves complex immune dysregulation within the intestinal mucosa.
- Intestinal epithelial cells (IECs) play a critical role in maintaining gut homeostasis and immune responses.
- Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) is a C-type lectin receptor implicated in immune cell interactions.
Purpose of the Study:
- To investigate the expression and role of DC-SIGN in IECs within the context of IBD.
- To explore the correlation between DC-SIGN expression and disease activity in IBD patients and a mouse model.
- To assess the impact of targeting DC-SIGN on T cell responses in experimental colitis.
Main Methods:
- Immunohistochemistry and flow cytometry were used to assess DC-SIGN expression in IECs from IBD patients and a dextran sodium sulfate (DSS)-induced colitis mouse model.
- Disease activity and histopathology scores were evaluated to correlate DC-SIGN levels with disease severity.
- T cell activation, cytokine production (IL-4, IFN-γ), and proliferation were analyzed in co-culture experiments involving IECs and T cells, with and without anti-P-selectin lectin-EGF domain monoclonal antibody (PsL-EGFmAb) treatment.
Main Results:
- DC-SIGN expression was significantly elevated in IECs of IBD patients (Crohn's disease and ulcerative colitis) and mice with DSS-induced colitis compared to controls.
- DC-SIGN expression strongly correlated with disease severity in both human IBD and the mouse model.
- IECs from colitis models promoted T cell proliferation and IL-4 production, while dendritic cells induced a T-helper-1 phenotype; treatment with PsL-EGFmAb suppressed DC-SIGN expression and modulated T cell differentiation and proliferation.
Conclusions:
- IECs regulate intestinal immune responses in IBD, with DC-SIGN playing a key regulatory role.
- Increased DC-SIGN expression in IECs is associated with IBD pathogenesis and severity.
- Targeting DC-SIGN may represent a potential therapeutic avenue for managing IBD by modulating T cell responses.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Renewal of Intestinal Stem Cells
Inflammatory Bowel Disease I: Introduction
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

